Literature DB >> 33767177

Targeting macrophages in cancer immunotherapy.

Zhaojun Duan1,2, Yunping Luo3,4.   

Abstract

Immunotherapy is regarded as the most promising treatment for cancers. Various cancer immunotherapies, including adoptive cellular immunotherapy, tumor vaccines, antibodies, immune checkpoint inhibitors, and small-molecule inhibitors, have achieved certain successes. In this review, we summarize the role of macrophages in current immunotherapies and the advantages of targeting macrophages. To better understand and make better use of this type of cell, their development and differentiation characteristics, categories, typical markers, and functions were collated at the beginning of the review. Therapeutic strategies based on or combined with macrophages have the potential to improve the treatment efficacy of cancer therapies.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33767177      PMCID: PMC7994399          DOI: 10.1038/s41392-021-00506-6

Source DB:  PubMed          Journal:  Signal Transduct Target Ther        ISSN: 2059-3635


  279 in total

1.  Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells.

Authors:  Aikou Okamoto; Takashi Nikaido; Kazunori Ochiai; Satoshi Takakura; Misato Saito; Yuko Aoki; Nobuya Ishii; Nozomu Yanaihara; Kyosuke Yamada; Osamu Takikawa; Rie Kawaguchi; Seiji Isonishi; Tadao Tanaka; Mitsuyoshi Urashima
Journal:  Clin Cancer Res       Date:  2005-08-15       Impact factor: 12.531

2.  STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade.

Authors:  Juan Fu; David B Kanne; Meredith Leong; Laura Hix Glickman; Sarah M McWhirter; Edward Lemmens; Ken Mechette; Justin J Leong; Peter Lauer; Weiqun Liu; Kelsey E Sivick; Qi Zeng; Kevin C Soares; Lei Zheng; Daniel A Portnoy; Joshua J Woodward; Drew M Pardoll; Thomas W Dubensky; Young Kim
Journal:  Sci Transl Med       Date:  2015-04-15       Impact factor: 17.956

Review 3.  Origins and tissue-context-dependent fates of blood monocytes.

Authors:  Chen Varol; Simon Yona; Steffen Jung
Journal:  Immunol Cell Biol       Date:  2008-12-02       Impact factor: 5.126

Review 4.  Origin and specialization of splenic macrophages.

Authors:  Noelia A-Gonzalez; Antonio Castrillo
Journal:  Cell Immunol       Date:  2018-05-15       Impact factor: 4.868

5.  Dendritic cell and macrophage heterogeneity in vivo.

Authors:  Daigo Hashimoto; Jennifer Miller; Miriam Merad
Journal:  Immunity       Date:  2011-09-23       Impact factor: 31.745

6.  The origin and function of tumor-associated macrophages.

Authors:  Yang Liu; Xuetao Cao
Journal:  Cell Mol Immunol       Date:  2014-09-15       Impact factor: 11.530

7.  The cellular and molecular origin of tumor-associated macrophages.

Authors:  Ruth A Franklin; Will Liao; Abira Sarkar; Myoungjoo V Kim; Michael R Bivona; Kang Liu; Eric G Pamer; Ming O Li
Journal:  Science       Date:  2014-05-08       Impact factor: 47.728

8.  Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.

Authors:  G Dranoff; E Jaffee; A Lazenby; P Golumbek; H Levitsky; K Brose; V Jackson; H Hamada; D Pardoll; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

9.  OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis.

Authors:  Y Y Kong; H Yoshida; I Sarosi; H L Tan; E Timms; C Capparelli; S Morony; A J Oliveira-dos-Santos; G Van; A Itie; W Khoo; A Wakeham; C R Dunstan; D L Lacey; T W Mak; W J Boyle; J M Penninger
Journal:  Nature       Date:  1999-01-28       Impact factor: 49.962

10.  Macrophage-Mediated Trogocytosis Leads to Death of Antibody-Opsonized Tumor Cells.

Authors:  Ramraj Velmurugan; Dilip K Challa; Sripad Ram; Raimund J Ober; E Sally Ward
Journal:  Mol Cancer Ther       Date:  2016-05-25       Impact factor: 6.261

View more
  67 in total

Review 1.  Nanoparticles for generating antigen-specific T cells for immunotherapy.

Authors:  Savannah E Est-Witte; Natalie K Livingston; Mary O Omotoso; Jordan J Green; Jonathan P Schneck
Journal:  Semin Immunol       Date:  2021-12-23       Impact factor: 11.130

Review 2.  Dual Effect of Immune Cells within Tumour Microenvironment: Pro- and Anti-Tumour Effects and Their Triggers.

Authors:  Alicia Cristina Peña-Romero; Esteban Orenes-Piñero
Journal:  Cancers (Basel)       Date:  2022-03-25       Impact factor: 6.639

Review 3.  Prostate cancer immunotherapy: a review of recent advancements with novel treatment methods and efficacy.

Authors:  Ian Wang; Liankun Song; Beverly Y Wang; Arash Rezazadeh Kalebasty; Edward Uchio; Xiaolin Zi
Journal:  Am J Clin Exp Urol       Date:  2022-08-15

Review 4.  Pharmacological targeting of the tumor-immune symbiosis in glioblastoma.

Authors:  Lizhi Pang; Fatima Khan; Madeline Dunterman; Peiwen Chen
Journal:  Trends Pharmacol Sci       Date:  2022-05-07       Impact factor: 17.638

Review 5.  Macrophage-Derived Extracellular Vesicles: A Promising Tool for Personalized Cancer Therapy.

Authors:  Antonella Barone; Nicola d'Avanzo; Maria Chiara Cristiano; Donatella Paolino; Massimo Fresta
Journal:  Biomedicines       Date:  2022-05-27

6.  Identification of a cytokine-dominated immunosuppressive class in squamous cell lung carcinoma with implications for immunotherapy resistance.

Authors:  Minglei Yang; Chenghao Lin; Yanni Wang; Kang Chen; Haiyue Zhang; Weizhong Li
Journal:  Genome Med       Date:  2022-07-08       Impact factor: 15.266

7.  Immunomodulation and delivery of macrophages using nano-smooth drug-loaded magnetic microrobots for dual targeting cancer therapy.

Authors:  Xiaoxia Song; Wei Fu; U Kei Cheang
Journal:  iScience       Date:  2022-06-02

Review 8.  The Role of Atypical Chemokine Receptor D6 (ACKR2) in Physiological and Pathological Conditions; Friend, Foe, or Both?

Authors:  Arezoo Gowhari Shabgah; Farhad Jadidi-Niaragh; Hamed Mohammadi; Farnoosh Ebrahimzadeh; Maziar Oveisee; Abbas Jahanara; Jamshid Gholizadeh Navashenaq
Journal:  Front Immunol       Date:  2022-05-23       Impact factor: 8.786

9.  The Role of Monocytes and Macrophages in Homeostasis and Disease and Novel Avenues for Putative Treatments.

Authors:  Malgorzata Kloc; Jacek Z Kubiak
Journal:  Int J Mol Sci       Date:  2021-05-06       Impact factor: 5.923

Review 10.  Therapeutic Targeting of the Leukaemia Microenvironment.

Authors:  Vincent Kuek; Anastasia M Hughes; Rishi S Kotecha; Laurence C Cheung
Journal:  Int J Mol Sci       Date:  2021-06-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.